Literature DB >> 21342182

Nucleotide-binding and oligomerization domain-like receptors and retinoic acid inducible gene-like receptors in human tonsillar T lymphocytes.

Terese Petterson1, Anne Månsson, Kristian Riesbeck, Lars O Cardell.   

Abstract

Nucleotide-binding and oligomerization domain (NOD)-like receptors (NLRs) and retinoic acid-inducible gene (RIG)-like receptors (RLRs) are recently discovered cytosolic pattern-recognition receptors sensing mainly bacterial components and viral RNA, respectively. Their importance in various cells and disorders is becoming better understood, but their role in human tonsil-derived T lymphocytes remains to be elucidated. In this study, we evaluated expression and functional relevance of NLRs and RLRs in human tonsillar CD3(+) T lymphocytes. Immunohistochemistry, real-time RT-PCR and flow cytometry revealed expression of NOD1, NOD2, NALP1, NALP3, NAIP, IPAF, RIG-1, MDA-5 and LGP-2 at mRNA and protein levels. Because of the limited number of ligands (iE-DAP, MDP, Alum, Poly(I:C)/LyoVec), functional evaluation was restricted to NOD1, NOD2, NALP3 and RIG-1/MDA-5, respectively. Stimulation with the agonists alone was not enough to induce activation but upon triggering via CD3 and CD28, a profound induction of proliferation was seen in purified CD3(+) T cells. However, the proliferative response was not further enhanced by the cognate ligands. Nonetheless, in tonsillar mononuclear cells iE-DAP, MDP and Poly(I:C)/LyoVec were found to augment the CD3/CD28-induced proliferation of tonsillar mononuclear cells. Also, iE-DAP and MDP were found to promote secretion of interleukins 2 and 10 as well as to up-regulate CD69. This study demonstrates for the first time a broad range of NLRs and RLRs in human tonsillar T cells and that NOD1, NOD2 and RIG-1/MDA-5 act synergistically with αCD3 and αCD28 to induce proliferation of human T cells. Hence, these results suggest that these receptors have a role in T-cell activation.
© 2011 The Authors. Immunology © 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21342182      PMCID: PMC3088970          DOI: 10.1111/j.1365-2567.2011.03414.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  41 in total

Review 1.  Expression and function of Toll-like receptors in T lymphocytes.

Authors:  Dieter Kabelitz
Journal:  Curr Opin Immunol       Date:  2006-11-28       Impact factor: 7.486

Review 2.  Nod-like proteins in immunity, inflammation and disease.

Authors:  Jörg H Fritz; Richard L Ferrero; Dana J Philpott; Stephen E Girardin
Journal:  Nat Immunol       Date:  2006-12       Impact factor: 25.606

Review 3.  Toll-like receptor polymorphisms and susceptibility to human disease.

Authors:  E Ann Misch; Thomas R Hawn
Journal:  Clin Sci (Lond)       Date:  2008-03       Impact factor: 6.124

Review 4.  Toll-like receptor and RIG-I-like receptor signaling.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

Review 5.  The roles of TLRs, RLRs and NLRs in pathogen recognition.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Int Immunol       Date:  2009-02-26       Impact factor: 4.823

Review 6.  Function of Nod-like receptors in microbial recognition and host defense.

Authors:  Luigi Franchi; Neil Warner; Kyle Viani; Gabriel Nuñez
Journal:  Immunol Rev       Date:  2009-01       Impact factor: 12.988

7.  Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome.

Authors:  Mirjam Kool; Virginie Pétrilli; Thibaut De Smedt; Aline Rolaz; Hamida Hammad; Menno van Nimwegen; Ingrid M Bergen; Rosa Castillo; Bart N Lambrecht; Jürg Tschopp
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

Review 8.  Pattern recognition receptors and control of adaptive immunity.

Authors:  Noah W Palm; Ruslan Medzhitov
Journal:  Immunol Rev       Date:  2009-01       Impact factor: 12.988

Review 9.  Interleukin-2 in the development and control of inflammatory disease.

Authors:  Katrina K Hoyer; Hans Dooms; Luke Barron; Abul K Abbas
Journal:  Immunol Rev       Date:  2008-12       Impact factor: 12.988

10.  Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants.

Authors:  Stephanie C Eisenbarth; Oscar R Colegio; William O'Connor; Fayyaz S Sutterwala; Richard A Flavell
Journal:  Nature       Date:  2008-05-21       Impact factor: 49.962

View more
  18 in total

1.  NOD-like receptors and RIG-I-like receptors in human eosinophils: activation by NOD1 and NOD2 agonists.

Authors:  Anne Månsson Kvarnhammar; Terese Petterson; Lars-Olaf Cardell
Journal:  Immunology       Date:  2011-11       Impact factor: 7.397

2.  Nod2 Deficiency Augments Th17 Responses and Exacerbates Autoimmune Arthritis.

Authors:  Ruth J Napier; Ellen J Lee; Emily E Vance; Paige E Snow; Kimberly A Samson; Clare E Dawson; Amy E Moran; Peter Stenzel; Michael P Davey; Shimon Sakaguchi; Holly L Rosenzweig
Journal:  J Immunol       Date:  2018-08-27       Impact factor: 5.422

3.  Urate crystals induce NLRP3 inflammasome-dependent IL-1β secretion and proliferation in isolated primary human T-cells.

Authors:  T Eleftheriadis; G Pissas; G Antoniadi; P Makri; V Liakopoulos; I Stefanidis
Journal:  Hippokratia       Date:  2015 Jan-Mar       Impact factor: 0.471

Review 4.  RNAi therapeutic strategies for acute respiratory distress syndrome.

Authors:  Melissa L Jagrosse; David A Dean; Arshad Rahman; Bradley L Nilsson
Journal:  Transl Res       Date:  2019-07-27       Impact factor: 7.012

5.  Lack of Both Nucleotide-Binding Oligomerization Domain-Containing Proteins 1 and 2 Primes T Cells for Activation-Induced Cell Death.

Authors:  Sashi G Kasimsetty; Alana A Shigeoka; Andrew A Scheinok; Amanda L Gavin; Richard J Ulevitch; Dianne B McKay
Journal:  J Immunol       Date:  2017-06-26       Impact factor: 5.422

Review 6.  Current Progress in Non-viral RNAi-Based Delivery Strategies to Lymphocytes.

Authors:  Shoshy Mizrahy; Inbal Hazan-Halevy; Niels Dammes; Dalit Landesman-Milo; Dan Peer
Journal:  Mol Ther       Date:  2017-04-06       Impact factor: 11.454

7.  The Bacterial Peptidoglycan-Sensing Molecules NOD1 and NOD2 Promote CD8+ Thymocyte Selection.

Authors:  Marianne M Martinic; Irina Caminschi; Meredith O'Keeffe; Therese C Thinnes; Raelene Grumont; Steve Gerondakis; Dianne B McKay; David Nemazee; Amanda L Gavin
Journal:  J Immunol       Date:  2017-02-15       Impact factor: 5.422

8.  Uric acid induces caspase-1 activation, IL-1β secretion and P2X7 receptor dependent proliferation in primary human lymphocytes.

Authors:  T Eleftheriadis; G Pissas; A Karioti; G Antoniadi; S Golfinopoulos; V Liakopoulos; A Mamara; M Speletas; G Koukoulis; I Stefanidis
Journal:  Hippokratia       Date:  2013-04       Impact factor: 0.471

Review 9.  NOD1 and NOD2 in inflammatory and infectious diseases.

Authors:  Bruno C Trindade; Grace Y Chen
Journal:  Immunol Rev       Date:  2020-07-17       Impact factor: 12.988

10.  M tuberculosis in the adjuvant modulates time of appearance of CNS-specific effector T cells in the spleen through a polymorphic site of TLR2.

Authors:  Chiara Nicolò; Gabriele Di Sante; Annabella Procoli; Giuseppe Migliara; Alessia Piermattei; Mariagrazia Valentini; Giovanni Delogu; Achille Cittadini; Gabriela Constantin; Francesco Ria
Journal:  PLoS One       Date:  2013-02-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.